unexplained antibody-drug conjugate

unknown · unknown

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for unexplained antibody-drug conjugate, covering 2020-07-24 to 2020-07-24. Get the full timeline:

Most recent: First antibody-drug conjugate for multiple myeloma patients with limited treatment options